Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
major histocompatibility complex, class II, DP alpha 2 (pseudogene) | 0.780 | 0.538 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2007 | 2007 | |||||||||
|
dynein axonemal heavy chain 2 | 0.931 | 0.115 | 1.3E-44 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
interferon induced with helicase C domain 1 | 0.471 | 0.808 | 7.0E-44 |
|
disease | 0.200 | None | 0.927 | 3 | 1 | 2006 | 2018 | ||||||||
|
notch receptor 4 | 0.534 | 0.731 | 2.1E-23 |
|
disease | 0.100 | None | 1.000 | 1 | 12 | 2007 | 2007 | ||||||||
|
Ski2 like RNA helicase | 0.615 | 0.654 | 1.3E-22 |
|
disease | 0.100 | None | 1.000 | 1 | 3 | 2007 | 2007 | ||||||||
|
KIAA1109 | 0.603 | 0.654 | 3.3E-21 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2007 | 2015 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.900 | None | 0.945 | 4 | 1 | 2004 | 2020 | ||||||||
|
valyl-tRNA synthetase 2, mitochondrial | 0.666 | 0.577 | 5.8E-17 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2007 | 2007 | ||||||||
|
complement C2 | 0.617 | 0.692 | 1.3E-16 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2007 | 2007 | ||||||||
|
testis expressed basic protein 1 | 0.638 | 0.692 | 1.5E-16 |
|
disease | 0.100 | None | 1.000 | 1 | 17 | 2007 | 2007 | ||||||||
|
complement factor B | 0.532 | 0.769 | 4.7E-16 |
|
disease | 0.200 | None | 0.917 | 1 | 1 | 1979 | 2015 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.200 | None | 1.000 | 1 | 1 | 1999 | 2018 | ||||||||
|
erb-b2 receptor tyrosine kinase 3 | 0.448 | 0.808 | 1.7E-15 |
|
disease | 0.200 | None | 1.000 | 4 | 2 | 2007 | 2019 | ||||||||
|
signal regulatory protein gamma | 0.821 | 0.231 | 3.5E-15 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 2009 | 2019 | ||||||||
|
phosphoglucomutase 1 | 0.628 | 0.577 | 5.1E-15 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 1994 | 2009 | ||||||||
|
solute carrier family 44 member 4 | 0.678 | 0.615 | 1.0E-14 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2007 | 2007 | ||||||||
|
von Willebrand factor A domain containing 7 | 0.839 | 0.308 | 2.3E-11 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2007 | 2007 | ||||||||
|
mutS homolog 5 | 0.641 | 0.692 | 3.2E-11 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2007 | 2009 | ||||||||
|
tripartite motif containing 40 | 0.890 | 0.192 | 6.2E-11 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2007 | 2007 | ||||||||
|
transporter 2, ATP binding cassette subfamily B member | 0.517 | 0.808 | 6.9E-11 |
|
disease | 0.200 | None | 0.800 | 1 | 12 | 1993 | 2015 | ||||||||
|
butyrophilin like 2 | 0.546 | 0.808 | 8.6E-11 |
|
disease | 0.120 | None | 1.000 | 1 | 7 | 2005 | 2019 | ||||||||
|
ubiquitin associated and SH3 domain containing A | 0.638 | 0.538 | 1.0E-10 |
|
disease | 0.160 | None | 1.000 | 3 | 2 | 2009 | 2019 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.200 | None | 0.882 | 1 | 1 | 1990 | 2017 | ||||||||
|
ATP binding cassette subfamily F member 1 | 0.674 | 0.538 | 1.3E-09 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2007 | 2007 | ||||||||
|
serine/threonine kinase 19 | 0.691 | 0.500 | 6.7E-09 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2007 | 2007 |